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ABSTRACT 
To develop a simple, cheap, accurate, and rapid Reverse Phase High Performance Liquid Chromatographic (RP-HPLC) method and validate as 
per ICH guidelines for estimation of Didanosine in pharmaceutical dosage forms. The separation was conducted by using mobile phase 
consisting of methanol: water in the ratio (30:70). The wavelength was found at 246nm. Agilent 1220 Infinity LC with ezchrome software is 
used for chromatographic determination. The separation was conducted by using Zebra Eclipse XDB-C-18 (4.6×250×5µm) at the flow rate of 
1.0 ml/min using variable wavelength detector. The developed method resulted in didanosine eluting at 4.650 min.  The method was found to 
be linear over the concentration range 2-12µg/ml with coefficient regression R2-0.997. Mean recovery was found to be in the range of 99.99%, 
during accuracy studies. The limit of detection (LOD) and limit of quantitiation (LOQ) was found to be 5 mg/ml and 16 mg/ml respectively. A 
cheap, accurate, precise, linear and rapid RP-HPLC method was developed and validated for the quantitative estimation of Didanosine as per 
ICH guidelines.  
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INTRODUCTION: 
Didanosine chemically 2', 3’- dideoxyinosine (fig1) is an 
antiretroviral medication used to treat HIV/AIDS in 
combination with other medications as part of highly active 
antiretroviral therapy. An extensive review of the literature 
revealed a few analytical methods (1-12), was reported for 
the estimation of didanosine in dosage forms. Didanosine is 
a dideoxy analogue of the purine nucleoside inosine that 
potentially inhibits the replication of the human 
immunodeficiency virus. Analogue to other nucleoside 
inhibits, this compound also requires intracellular 
metabolism to the active triphosphate, 2', 3’- dideoxyinosine-
5-triphosphate (ddATP), which act as a competitive 
inhibitors of HIV reverse transcriptase or as a DNA chain 
transmitter. (13-14) Validation is the process of providing 
documented evidence what it is intended to do. In other 
word the process of method validation ensures that the 
proposed analytical methodology is accurate, specific, 
reproducible and rugged for its intended use. Analytical 
techniques have different degrees of sophistication, 
sensitivity and selectivity, as well as, different cost and time 
requirements. 
MATERIALS AND METHODS 
Chemicals and Reagents 
 Water, Methanol, Acetonitrile of Analytical and HPLC grade 
purchased from Arti pharmaceuticals (Mumbai). Ammonium 
acetate buffer of AR grade purchased from Raj Chemicals 
(Latur). 
Instrument 
HPLC analysis was performed on Agilent 1220 Infinity LC 
with EZchrome software with variable wavelength detector. 
With made of Agilent technologies, A manually operating 
Rheodyne injector with 20µl sample loop was equipped with 
the HPLC system.,Zobrax Eclipse XDBC18 column 
(4.6×150×5µm), Electronic weighing balance BL-220 H 
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made of Shimatzu Corporation, Hot air oven made of Nisco 
Company, Sonicator made of the Ultrasonic’s PCi Analytics 
sonicator. 
METHODS:- Selection of Wavelength suitable wavelength 
for the HPLC analysis was determined  by recording UV 
spectrum in the range of 200-400 nm for didanosine. 
Suitable wavelength selected was 246 nm (Figure 2). 
Figure 1 Chemical structure of Didanosine 
 
Figure 2 UV spectrum of Didanosine 
 
Figure 3 Typical Chromatogram of Blank solution 
 
Figure 4 Typical chromatogram of the standard solution 
 
 
 
Figure5 Typical chromatogram for the tablet 
formulation 
 
Figure 6 Calibration Curve 
 
 
CHROMATOGRAPHIC CONDITIONS: 
The developed method uses a reverse phase C18 column, 
Phenomena Gemini (C18 4.6×250×5µm), mobile phase 
consisting of a mixture of methanol: water in the ratio 
(30:70). The mobile phase was set at a flow rate of 1 ml/min 
and the volume injected was 20 µl for every injection. The 
detection wavelength was set at 246 nm. 
Preparation Mobile Phase 
A mixture of 30 volumes of Methanol, and 70 volumes of 
water was prepared (30:70). The mobile phase was sonicate 
for 10 min to remove gases. 
Preparation of standard stock solution 
Weigh accurately 10 mg of Didanosine drug in 100 ml 
volumetric flask and dissolve in 100 ml water. 
Preparation of sample solution 
20 Tablets (each tablet contains 10 mg of Didanosine) were 
weighed and taken into a mortar uniformly mixed. Test 
stock solutions of Didanosine (10µg/ml) and was prepared 
by dissolving weight equivalent to 10 mg of Didanosine and 
dissolved in sufficient mobile phase. After that filtered the 
solution using 0.45-micron syringe filter .after the filtration 
zsolicited for 5 min and dilute to 100 ml with mobile phase. 
Further dilutions are prepared in 5 replicates of 10µg/ml of 
Didanosine was made by adding 1 ml of stock solution to 10 
ml of mobile phase. 
Calibration Curve 
Appropriate aliquots of standard stock solution 
(1000µg/ml) was diluted to 100 mg/ml in 10ml volumetric 
flask and resultant solution was diluted up to the mark with 
mobile phase to obtain a final concentration of 2,4,6,8,10, 
and 12µg/ml. These solutions were injected into 
y = 636.26x + 385.06 
R² = 0.9977 
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chromatographic system. The chromatograms were 
obtained and peak area ratio was determined for each 
concentration of drug solution. Calibration curve of 
Didanosine were constructed by plotting peak area ratio vs 
applied concentration of Didanosine and regression 
equation was computed. The sample solution was 
chromatographic and concentration of didanosine in tablet 
samples was calculated using regression equation. 
RESULTS AND DISCUSSION 
METHOD DEVELOPMENT 
A Reverse phase HPLC method was developed considering 
the system suitability parameters i.e. tailing factor (T), the 
number of theoretical plates (N), run time and the cost 
effectiveness. The optimized method developed resulted in 
the elution of Didanosine at 4.560 min. Figures 3&4 
represent chromatograms of blank and standard solution 
(10µg/ml) respectively. The total run time is 10 minutes. 
System suitability tests are an integral part of method 
development and validation. System suitability tests are 
used to ensure adequate performance of the 
chromatographic system. System suitability parameters 
were evaluated for six replicate injections of the standard at 
working concentration. The results are given in Table 1. 
Table 1 System suitability studies results 
Parameters Didanosine 
Retention time (min) 4.650 
Number Of Theoretical 
plates(N) 
6245 
Tailing factor (T) 1.6 
  
Table 2 Calibration data for Didanosine 
Sr. No Concentration (µg/ml) Area (µAU) 
1 2 169062 
2 4 298014 
3 6 419805 
4 8 537160 
5 10 660275 
6 12 818992 
 
Table 3 Results of Accuracy studies for Didanosine 
Recovery level Accuracy Didanosine 
 
Amount of 
taken 
Area Average Area 
Amount 
recovered 
(mcg/ml) 
% Recovery 
Average % 
Recovery 
80 
2 169062 
168764 1.94 96% 
      97% 
2 169072 
2 168159 
100 
6 419805 
419310 5.94 98% 6 419710 
6 418415 
120 
10 660275 
660750 9.8 97% 10 661165 
10 660945 
 
Table 4 System precision results 
Didanosine   
Injection No. Rt Area 
1 4.631 670254 
2 4.650 675148 
3 4.550 670254 
4 4.642 674545 
5 4.551 676458 
6 4.650 673654 
AVG 4.612333 673385.5 
SD 0.0484011 2591.362 
%RSD 1.04938 0.4848 
Table 5 Intraday precision results 
Injection No. Rt Area 
1 5 664257 
2 5.01 664747 
3 4.99 664346 
4 4.99 664421 
5 5.1 664237 
6 5 664647 
AVG 5.015 664452 
SD 0.0423 210.216 
%RSD 0.8623 0.31 
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Table 6 Inter day precision results 
Injection No. Rt Area 
1 4.655 664803 
2 4.7 66472 
3 4.95 66509 
4 4.60 66429 
5 4.90 66501 
6 4.70 66519 
AVG 4.7508 664850.5 
SD 0.14072 326.039 
%RSD 1.20 0.490 
 
Table 7 Robustness results of Didanosine 
Parameters 
Flow 
0.8mn/min 4.7283 672957 
1.2ml/min 4.885 67296 
Wavelength 
244 4.7866 67338.5 
248 4.6866 674228.3 
 
METHOD VALIDATION (15-16) 
Authentification of the investigative method is the process 
that starts by laboratory studies in which the requirements 
of the performance properties of method are met for the 
intended analytical application. To the validation of 
analytical procedures RP-HPLC method developed was 
validated according to International Conference on 
Harmonization (ICH) and USP guidelines. Various 
parameters or criteria are used for the method of 
validification, such as linearity, accuracy, precision, system 
suitability, ruggedness, limit of Quantification (LOQ) and 
limit of Detection (LOD).  
System suitability parameters 
The system suitability parameters were determined by 
preparing standard solutions of Didanosine. The solutions 
were injected six times and the parameters are calculated 
which are % RSD, peak tailing, resolution and USP plate 
count. The results are mentioned in Table 1. The standard 
chromatogram is shown in Fig. 4. 
Specificity 
Figures 3-5 are for the blank determination, the standard 
drug solution and sample chromatograph mixture discloses 
that the peaks acquired in the standard solution and sample 
solution at working concentrations are acquired only 
because of the drugs, this is the reason that blank 
determinations show no peak at the retention time of 
didanosine. Accordingly it can be concluded that, the method 
developed is said to be accurate and specific. 
Linearity  
Linearity the method was tested from 80-120 % of the 
targeted level of the assay concentration for analyte. 
Standard solutions contained 2-12 µg/mL of didanosine. 
Linearity solutions were injected in triplicate. The equations 
of the calibration curves for Montelukast sodium obtained 
were y = 02E+06X in the didanosine determination, the 
calibration graphs were found to be linear in the 
aforementioned concentrations with correlation coefficients 
0.9978. The results are mentioned in the Table 2 & 
calibration curve Fig 6. 
Accuracy 
The precision was determined with the help of recovery 
experiments, by the verification with percentage mean 
recovery of sample at three different levels (80-120%). 20 
blank tablets were powdered and mixed.  This powder was 
then spiked with a quantity of didanosine corresponding to 
80%, 100% and 120% of the labeled claim. Each of these 
powder mixtures was analyzed in triplicate and the quantity 
of Didanosine was determined using calibration equation. 
Accuracy was reported as 98 % of didanosine recovered. The 
results are mentioned in Table 3.  
Precision   
System precision 
The value for %RSD (Relative Standard Deviation) was 
obtained less than 2 by six replicate injections of the 
standard solution at working concentrations, concerning the 
peak area for the drug. It designates the adequate 
reproducibility and hence the accuracy of the system. 
System precision results are tabulated in Table 4.   
Method precision 
The accuracy of procedure was determined by conducting 
assay of sample with the tests of (I) Repeatability (Intraday 
precision) and (II) Intermediate precision or ruggedness 
(Interday precision) completed within 3 successive 
daysbythree different analysts, at working concentration. 
Repeatability (Intraday precision)   
The value for %RSD (Relative Standard Deviation) less than 
2 for six successive injections of the sample solution from 
the same homogenous mixture at working concentrations, 
concerning % assay for the drug which indicate that the 
method developed is method precise by the test of 
repeatability and hence can be understood that the method 
gives consistently reproducible results (Table 5).  
Intermediate Precision (Ruggedness / Inter day 
precision) 
The value for %RSD (Relative Standard Deviation) less than 
2 for six successive injections of the sample solution from 
the same homogenous mixture at working concentrations on 
three successive days by three unidentical analysts for % 
assay for the drug within and between days, which indicate 
the method developed is inter day precise / rugged (Table 
6).  
Robustness  
The robustness of an analytical procedure is an estimate of 
its capacity to last unchanged by slight but intentional 
change in the analytical method parameters. To assess HPLC 
method robustness some measurable factors were 
intentionally changed. The factors comprise of variation of 
columns C8 (old & new), % of acetonitrile in the moving 
stage and acetonitrile of lots. Change in wavelength ± 2nm 
Change in flow rate ±0.2 ml/min. The results are mentioned 
in Table 7.  
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Limit of Detection (LOD)  
The limit of detection (LOD) of methodological (analytical) 
process is defined as the concentration that produce 
instrument signal that is notably distinct from the blank 
determination. The IUPAC approach utilize the standard 
deviation of the intercept (Sa) for the spectroscopic 
techniques or other methods that depend upon a calibration 
curve for quantitative measurements, which may be related 
to LOD and the slope of the calibration curve, b. The limit of 
detection was found to be 5ng/ml  
Limit of Quantification (LOQ)  
The LOQ is the concentration that can be quantitate reliably 
with a specified level of accuracy and precision. The LOQ 
represent the concentration of analyte that would yield a 
signal-to-noise ratio of 10.The limit of quantification was 
found to be 15 mg/ml. 
CONCLUSION 
Method development and validation of model drug 
Didanosine was carried out under the circumstances of 
using mobile Water which give sharp peak and UV spectra 
also. A very few analytical method found in literature survey 
for the determination of Didanosine including FTIR, 
spectrophotometer. The develop UV and HPLC method was 
found to be simple, rapid, selective accurate, precise for the 
concurrent estimation of drug in dosage form. The method 
was evaluated in best condition, linear relation including 
coefficient of correlation, linearity, robustness, and accuracy, 
precision. The percent RSD for all parameter was found to be 
less than two which indicate the validity of method and 
assay result obtained by this method are in fair agreement. 
The force degradation studies performing in acidic, basic, 
neutral, Photo stability also performed. 
All result obtained with proposed method confirm the 
suitability of these method for the analysis of 
pharmaceutical dosage form. The proposed method has been 
successfully applied for routine in process quality control.  
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